Caring Brands Completes $4 Million Offering Following Nasdaq Uplisting

Caring Brands, Inc. (NASDAQ: CABR) has closed an underwritten U.S. public offering of 1,000,000 shares of common stock at $4.00 per share, generating gross proceeds of approximately $4 million before underwriting discounts and expenses. This offering coincides with the company's successful uplisting to the Nasdaq Capital Market, where its shares commenced trading on November 13, 2025. The company also granted the underwriter a 45-day option to purchase up to 150,000 additional shares. According to the company, the net proceeds from the offering are intended for general working capital purposes, marketing and sales initiatives for its proprietary products, and the repayment of certain outstanding debt.

The uplisting to Nasdaq represents a significant milestone for Caring Brands, potentially enhancing its visibility and accessibility to a broader range of institutional and retail investors. The capital infusion from the offering is expected to support the advancement of the company's diverse product pipeline. Caring Brands operates as a wellness consumer products company, offering several over-the-counter and cosmetic products. Its development pipeline includes a range of treatments targeting specific health and wellness needs, such as hair loss treatments, solutions for eczema and psoriasis, vitiligo treatments, and a specialized suncare line designed to protect against jellyfish stings. More information about the company's operations can be found at https://caringbrands.com/.

The company emphasizes a method of operation that prioritizes scientific validation and commercial viability. This approach involves establishing the mechanism of action for all products, determining efficacy through controlled clinical trials, securing product protection via issued and filed patents, and ensuring acceptable commercial stability. The successful offering and market uplisting provide the financial resources to further execute this strategy across its product portfolio. The press release detailing these developments was distributed by BioMedWire, a specialized communications platform focused on the biotechnology and life sciences sectors. The full announcement is available at https://ibn.fm/t7l6W.

This financial and corporate development is important as it provides Caring Brands with the capital necessary to accelerate the commercialization of its clinical-stage wellness products. Access to public markets via Nasdaq and the fresh capital can enable expanded marketing efforts, debt reduction, and continued research and development, which are critical for bringing its targeted health solutions to market. For investors, the move signifies the company's progression and its commitment to scaling operations in the competitive consumer wellness industry.